James E. Mills

Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss

Andrew Fedoriw, Satyajit Rajapurkar, Shane W. O’Brien et al. · Cancer Cell · 2019 · 333 citations · Full text

Cancer Research, Mtap Loss, Medicine +10

Three-dimensional hydrogen-bond geometry and probability information from a crystal survey

James E. Mills, P. M. Dean · Journal of Computer-Aided Molecular Design · 1996 · 263 citations

Crystal Structure, Engineering, Physics +9

Rapid Discovery of a Novel Series of Abl Kinase Inhibitors by Application of an Integrated Microfluidic Synthesis and Screening Platform

Bimbisar Desai, Karen Dixon, Elizabeth Farrant et al. · Journal of Medicinal Chemistry · 2013 · 140 citations · Full text

Selective Inhibitors of Protozoan Protein N-myristoyltransferases as Starting Points for Tropical Disease Medicinal Chemistry Programs

Andrew Bell, James E. Mills, Gareth Williams et al. · PLoS neglected tropical diseases · 2012 · 93 citations · Full text

Drug Target, Bioorganic Chemistry, Malaria +22

Aromatic chloride to nitrile transformation: medicinal and synthetic chemistry

Lyn H. Jones, Nicholas W. Summerhill, Nigel A. Swain et al. · MedChemComm · 2010 · 88 citations

Medicinal Chemistry, Aromatic Chloride, Heterocyclic +12